Patents by Inventor Mark Ian Christie

Mark Ian Christie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the treatment of multiple sclerosis by inhibiting IL-17 activity
    Patent number: 7931900
    Abstract: The present invention provides a method for the treatment and/or prophylaxis of multiple sclerosis (MS) comprising administering a therapeutically effective amount of an inhibitor of IL-17 activity.
    Type: Grant
    Filed: November 24, 2008
    Date of Patent: April 26, 2011
    Assignee: UCB Pharma S.A.
    Inventors: Mark Ian Christie, Richard James Mead, Martyn Kim Robinson, Stephen Edward Rapecki
  • Method for the Treatment of Multiple Sclerosis by Inhibiting IL-17 Activity
    Publication number: 20090191200
    Abstract: The present invention provides a method for the treatment and/or prophylaxis of multiple sclerosis (MS) comprising administering a therapeutically effective amount of an inhibitor of IL-17 activity.
    Type: Application
    Filed: November 24, 2008
    Publication date: July 30, 2009
    Applicant: CELLTECH R&D LIMITED
    Inventors: Mark Ian Christie, Richard James Mead, Martyn Kim Robinson, Stephen Edward Rapecki